 |
市场调查报告书
商品编码
1895797
ADME毒理学检测市场规模、份额和成长分析（按方法、技术、应用、最终用户和地区划分）—产业预测（2026-2033年）ADME Toxicology Testing Market Size, Share, and Growth Analysis, By Method (Cellular Assay, Biochemical Assay), By Technology (Cell Culture, High Throughput), By Application, By End Users, By Region - Industry Forecast 2026-2033 |
||||||
预计 2024 年 ADME 毒性测试市场规模将达到 116.5 亿美元，从 2025 年的 130.5 亿美元成长到 2033 年的 323.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 12%。
ADME毒性测试市场对于评估各种物质的药物动力学和药物动力学至关重要，能够提供吸收、分布、代谢和排泄过程的重要资讯。在法规结构日益严格的背景下，安全有效的药物需求不断增长，ADME测试在早期药物开发和非临床安全性评估中发挥关键作用。製药公司和研究人员利用ADME测试来识别潜在毒性并表征候选药物的药物动力学特征。然而，人体生理的复杂性、个体差异以及适应不断变化的法规等挑战可能会影响试管内的准确性。同时，体外和电脑模拟方法的进步以及个人化医疗的应用，正在为市场创造巨大的机会，并凸显了药物开发中对安全性和有效性的持续重视。
ADME毒性测试市场驱动因素
ADME毒性测试市场的成长主要得益于製药业对药物研发日益增长的重视，而对创新疗法的需求至关重要。致力于发现和开发针对各种疾病的有效疗法的机构越来越依赖毒性测试，以确保候选药物符合安全性和有效性标准。这项严格的评估流程对于製药公司和研究机构至关重要，它能够检验化合物在进入临床试验之前以及最终上市前的安全性和有效性，确保病患安全和符合监管要求。
限制 ADME 毒性测试市场的因素
ADME毒性测试市场面临着巨大的经济负担，这主要源于测试过程涉及多种调查方法、专用设备以及合格人员的专业技能。对于预算较为紧张的中小型製药公司而言，这些成本尤其阻碍因素。因此，高昂的毒性测试费用会抑制这些公司对关键研发倡议的投入，从而扼杀创新，并降低其在对安全性评估要求严格的市场中的竞争力。
ADME毒性测试市场趋势
ADME毒性测试市场正日益受到体外和电脑模拟调查方法进步的推动，这些方法为传统的动物试验提供了高效、经济且符合伦理的替代方案。创新体外检测方法与先进预测建模技术的结合，正在提高毒性评估的准确性和可靠性。这些技术突破不仅简化了药物研发流程，也满足了监管机构和社会对人道研究方法的需求。随着各组织寻求提升其毒性评估能力，这些前沿方法的应用预计将显着影响ADME毒性测试市场的未来模式。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
全球 ADME 毒性测试市场规模（按方法论和复合年增长率划分）（2026-2033 年）
- 细胞分析
- 生化分析
- In silico
- Ex-vivo
全球ADME毒理学检测市场规模（依技术及复合年增长率划分）（2026-2033年）
- 细胞培养
- 高通量
- 分子影像
- 体学技术
全球 ADME 毒理学检测市场规模（按应用及复合年增长率划分）（2026-2033 年）
- 全身毒性
- 肾毒性
- 肝毒性
- 神经毒性
- 其他的
全球 ADME 毒性测试市场规模（按最终用户和复合年增长率划分）（2026-2033 年）
- 医院和诊所
- 诊断中心
- 病理检查室
- 其他的
全球 ADME 毒理学检测市场规模（按地区划分）及复合年增长率（2026-2033 年）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- Charles River Laboratories（USA）
- Eurofins Scientific（Luxembourg）
- WuXi AppTec（China）
- SGS SA（Switzerland）
- PPD（USA）
- Covance Inc.（USA）
- ICON plc（Ireland）
- LabCorp（USA）
- Syneos Health（USA）
- IQVIA（USA）
- Boehringer Ingelheim（Germany）
- Merck & Co.（USA）
- Pfizer Inc.（USA）
- Novartis AG（Switzerland）
- AstraZeneca（UK）
- GlaxoSmithKline plc（UK）
- Sanofi（France）
- Johnson & Johnson（USA）
- AbbVie Inc.（USA）
- Eli Lilly and Company（USA）
结论与建议
ADME Toxicology Testing Market size was valued at USD 11.65 Billion in 2024 and is poised to grow from USD 13.05 Billion in 2025 to USD 32.31 Billion by 2033, growing at a CAGR of 12% during the forecast period (2026-2033).
The ADME toxicology testing market is essential for evaluating the pharmacokinetics and toxicokinetics of various substances, offering critical insights into absorption, distribution, metabolism, and elimination processes. This testing is pivotal in early-stage drug development and preclinical safety assessments, addressing the increasing demand for safer, more efficient pharmaceuticals amid rigorous regulatory frameworks. Pharmaceutical companies and researchers utilize ADME testing to identify potential toxicity and characterize pharmacokinetic profiles of drug candidates. However, challenges such as human physiological complexity, interindividual variations, and the need to adapt to evolving regulations can impact test accuracy. Conversely, advancements in in vitro and in silico methodologies, along with personalized medicine applications, present significant opportunities within the market, highlighting a continued emphasis on safety and efficacy in drug development.
Top-down and bottom-up approaches were used to estimate and validate the size of the ADME Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
ADME Toxicology Testing Market Segments Analysis
Global ADME Toxicology Testing Market is segmented by Method, Technology, Application, End Users and region. Based on Method, the market is segmented into Cellular Assay, Biochemical Assay, In Silica and Ex-vivo. Based on Technology, the market is segmented into Cell Culture, High Throughput, Molecular Imaging and OMICS Technology. Based on Application, the market is segmented into Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity and Others. Based on End Users, the market is segmented into Hospitals and clinics, Diagnostic centers, Pathological Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the ADME Toxicology Testing Market
The growth of the ADME Toxicology Testing market is significantly influenced by the increasing emphasis on drug development within the pharmaceutical industry, where the demand for innovative therapeutic solutions is paramount. As organizations strive to discover and create effective treatments for a wide range of health conditions, there is an escalating reliance on toxicology testing to ensure that drug candidates meet safety and efficacy standards. This rigorous evaluation process is essential for pharmaceutical companies and research institutions as they seek to validate their compounds prior to entering clinical trials and ultimately launching products into the market, ensuring patient safety and regulatory compliance.
Restraints in the ADME Toxicology Testing Market
The ADME Toxicology Testing market faces challenges due to the substantial financial burden linked to the testing processes, which encompass a range of experimental methodologies, specialized equipment, and the expertise of qualified personnel. These expenses can be particularly restrictive for smaller and medium-sized pharmaceutical firms that operate within tighter budget constraints. As a result, the high costs associated with comprehensive toxicology testing hinder the ability of these companies to invest in critical research and development initiatives, potentially stalling innovation and limiting their competitive capability in a market that demands rigorous safety assessments.
Market Trends of the ADME Toxicology Testing Market
The ADME Toxicology Testing market is increasingly driven by advancements in in vitro and in silico testing methodologies, which present efficient, cost-effective, and ethical alternatives to traditional animal testing. The integration of innovative in vitro assays and sophisticated predictive modeling techniques is enhancing the accuracy and reliability of toxicology evaluations. These technological breakthroughs not only streamline the drug development process but also align with the growing regulatory and societal demand for humane research practices. As organizations seek to improve their toxicology assessment capabilities, the adoption of these cutting-edge methods is expected to shape the future landscape of the ADME Toxicology Testing market significantly.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global ADME Toxicology Testing Market Size by Method & CAGR (2026-2033)
- Market Overview
- Cellular Assay
- Biochemical Assay
- In Silica
- Ex-vivo
Global ADME Toxicology Testing Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
Global ADME Toxicology Testing Market Size by Application & CAGR (2026-2033)
- Market Overview
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Others
Global ADME Toxicology Testing Market Size by End Users & CAGR (2026-2033)
- Market Overview
- Hospitals and clinics
- Diagnostic centers
- Pathological Labs
- Others
Global ADME Toxicology Testing Market Size & CAGR (2026-2033)
- North America (Method, Technology, Application, End Users)
- US
- Canada
- Europe (Method, Technology, Application, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Method, Technology, Application, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Method, Technology, Application, End Users)
- Brazil
- Rest of Latin America
- Middle East & Africa (Method, Technology, Application, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Charles River Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WuXi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SGS SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PPD (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Covance Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LabCorp (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syneos Health (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- IQVIA (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
ADME 毒性测试市场分析及预测（至 2034 年）：类型、产品、服务、技术、组件、应用、最终用户、模组、功能、阶段
ADME毒理学测试市场规模、份额、趋势及预测（按技术、产品类型、方法、应用和地区），2025-2033年
ADME 毒理学测试市场规模、份额、趋势分析报告：按技术、按应用、按方法、按地区、细分市场预测，2025-2030 年
全球 ADME 毒理学测试市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测In Vitro ADME检验服务的全球市场规模:各类型，各用途，各地区，范围及预测